Azithromycin (AZM) reduces death or severe respiratory morbidity at 12 month adjusted age (AA) in Ureaplasma-positive intubated preterms.

R. Viscardi (Baltimore, MD, United States of America), M. Terrin (Baltimore, MD, United States of America), L. Magder (Baltimore, MD, United States of America), S. Dulkerian (Baltimore, MD, United States of America), N. Davis (Baltimore, MD, United States of America), K. Waites (Birmingham, AL, United States of America), N. Ambalavanan (Birmingham, AL, United States of America), P. Donohue (Baltimore, MD, United States of America), D. Kaufman (Charlottesville, VA, United States of America), D. Tuttle (Newark,DE, United States of America), J. Weitkamp (Nashville, TN, United States of America)

Source: International Congress 2018 – Prematurity and lung disease
Session: Prematurity and lung disease
Session type: Oral Presentation
Number: 301
Disease area: Paediatric lung diseases, Respiratory critical care

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Viscardi (Baltimore, MD, United States of America), M. Terrin (Baltimore, MD, United States of America), L. Magder (Baltimore, MD, United States of America), S. Dulkerian (Baltimore, MD, United States of America), N. Davis (Baltimore, MD, United States of America), K. Waites (Birmingham, AL, United States of America), N. Ambalavanan (Birmingham, AL, United States of America), P. Donohue (Baltimore, MD, United States of America), D. Kaufman (Charlottesville, VA, United States of America), D. Tuttle (Newark,DE, United States of America), J. Weitkamp (Nashville, TN, United States of America). Azithromycin (AZM) reduces death or severe respiratory morbidity at 12 month adjusted age (AA) in Ureaplasma-positive intubated preterms.. 301

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: